Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ZBIO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 60,000 | $16.88 | $1.0M Buy | Form 4 ↗ |
| Apr 29, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 35,000 | $17.62 | $616.7K Buy | Form 4 ↗ |
| Apr 28, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 25,000 | $18.02 | $450.5K Buy | Form 4 ↗ |
| Mar 31, 2026 | Hongbo Lu Director | ZBIO Zenas BioPharma, Inc. | Buy | 3,768 | $18.63 | $70.2K Buy | Form 4 ↗ |
| Mar 31, 2026 | Tomas Kiselak Director | ZBIO Zenas BioPharma, Inc. | Buy | 150,000 | $20.00 | $3.0M Buy | Form 4 ↗ |
| Mar 31, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 34,000 | $19.31 | $656.5K Buy | Form 4 ↗ |
| Mar 31, 2026 | Hongbo Lu Director | ZBIO Zenas BioPharma, Inc. | Buy | 75,000 | $20.00 | $1.5M Buy | Form 4 ↗ |
| Mar 30, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 20,000 | $18.23 | $364.6K Buy | Form 4 ↗ |
| Feb 13, 2026 | Patricia L. Allen Director | ZBIO Zenas BioPharma, Inc. | Buy | 4,160 | $26.36 | $109.7K Buy | Form 4 ↗ |
| Feb 12, 2026 | Patricia L. Allen Director | ZBIO Zenas BioPharma, Inc. | Buy | 5,000 | $26.50 | $132.5K Buy | Form 4 ↗ |
| Feb 12, 2026 | Patricia L. Allen Director | ZBIO Zenas BioPharma, Inc. | Buy | 5,700 | $24.34 | $138.7K Buy | Form 4 ↗ |
| Feb 12, 2026 | Patricia L. Allen Director | ZBIO Zenas BioPharma, Inc. | Buy | 5,000 | $23.77 | $118.8K Buy | Form 4 ↗ |
| Feb 11, 2026 | Hongbo Lu Director | ZBIO Zenas BioPharma, Inc. | Buy | 25,985 | $22.50 | $584.7K Buy | Form 4 ↗ |
| Feb 2, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 57,000 | $17.96 | $1.0M Buy | Form 4 ↗ |
| Jan 9, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 20,000 | $16.55 | $331.0K Buy | Form 4 ↗ |
| Jan 8, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 30,000 | $16.30 | $489.0K Buy | Form 4 ↗ |
| Jan 7, 2026 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 50,000 | $16.38 | $819.0K Buy | Form 4 ↗ |
| Oct 9, 2025 | Jason Raleigh Nunn Director | ZBIO Zenas BioPharma, Inc. | Buy | 63,158 | $19.00 | $1.2M Buy | Form 4 ↗ |
| Oct 9, 2025 | Sr One Capital Management, LLC 10% owner | ZBIO Zenas BioPharma, Inc. | Buy | 63,157 | $19.00 | $1.2M Buy | Form 4 ↗ |
| Oct 9, 2025 | Sr One Capital Management, LLC 10% owner | ZBIO Zenas BioPharma, Inc. | Buy | 63,158 | $19.00 | $1.2M Buy | Form 4 ↗ |
| Oct 9, 2025 | Patrick G. Enright Director | ZBIO Zenas BioPharma, Inc. | Buy | 11,990 | $20.85 | $250.0K Buy | Form 4 ↗ |
| Oct 9, 2025 | Patrick G. Enright Director | ZBIO Zenas BioPharma, Inc. | Buy | 105,265 | $19.00 | $2.0M Buy | Form 4 ↗ |
| Oct 7, 2025 | Leon O. Moulder Jr. See Remarks, Director | ZBIO Zenas BioPharma, Inc. | Buy | 36,928 | $20.85 | $769.9K Buy | Form 4 ↗ |
| Oct 7, 2025 | Peter Evan Harwin Director | ZBIO Zenas BioPharma, Inc. | Buy | 316,219 | $19.00 | $6.0M Buy | Form 4 ↗ |
| Oct 7, 2025 | Hongbo Lu Director | ZBIO Zenas BioPharma, Inc. | Buy | 263,160 | $19.00 | $5.0M Buy | Form 4 ↗ |
| Feb 18, 2025 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 25,000 | $6.67 | $166.8K Buy | Form 4 ↗ |
| Feb 7, 2025 | Ting Xiao Director | ZBIO Zenas BioPharma, Inc. | Buy | 10,000 | $7.76 | $77.6K Buy | Form 4/A ↗ |
| Dec 4, 2024 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 45,000 | $9.98 | $449.1K Buy | Form 4 ↗ |
| Dec 3, 2024 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 25,000 | $10.76 | $269.0K Buy | Form 4 ↗ |
| Nov 19, 2024 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 2,500 | $14.57 | $36.4K Buy | Form 4 ↗ |
| Nov 18, 2024 | Leon O. Moulder Jr. Chief Executive Officer, Director | ZBIO Zenas BioPharma, Inc. | Buy | 7,500 | $15.00 | $112.5K Buy | Form 4 ↗ |
| Sep 13, 2024 | Hongbo Lu Director | ZBIO Zenas BioPharma, Inc. | Buy | 58,823 | $17.00 | $1000.0K Buy | Form 4 ↗ |
32 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 9:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances